Myrtle Potter - Rite Aid Director
| RADDelisted Stock | USD 0.17 0.01 5.56% |
Director
Ms. Myrtle S. Potter is no longer Independent Director of the Company effective Oct. 30, 2018. She has served since 2005 as the Chief Executive Officer of Myrtle Potter Company, LLC, a private consulting firm she founded, and from 2009 to 2014 as the Chief Executive Officer of Myrtle Potter Media, Inc., a consumer healthcare content company she founded. Ms. Potter previously served at Genentech, Inc., as President of Commercial Operations from 2004 to 2005 and as Executive Vice President, Commercial Operations and Chief Operating Officer from 2000 to 2004. From 1998 to 2000 Ms. Potter served as President of BristolMyers Squibb, Inc. Cardiovascular Metabolic U.S. operations. Ms. Potter serves as a director of Liberty Mutual Holding Company, Inc., Insmed, Inc., Everyday Health, Inc. and Proteus Digital Health, Inc. and as a trustee of The University of Chicago. Ms. Potter served on the board of Medco Health Solutions, Inc. from December 2007 until its acquisition by Express Scripts, Inc. in April 2012. She continued on the board at Express Scripts until June 2012.
| Age | 58 |
| Phone | 717 761 2633 |
| Web | https://www.riteaid.com |
Rite Aid Management Efficiency
Rite Aid's management efficiency ratios could be used to measure how well Rite Aid manages its routine affairs as well as how well it operates its assets and liabilities.The company has 5.82 B in debt. Rite Aid has a current ratio of 1.3, demonstrating that it may have difficulties to pay its financial commitments when the payables are due. Debt can assist Rite Aid until it has trouble settling it off, either with new capital or with free cash flow. So, Rite Aid's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rite Aid sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rite to invest in growth at high rates of return. When we think about Rite Aid's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Barry Rosenstein | Walgreens Boots Alliance | 55 | |
| Fengsheng Tan | Bimi International Medical | N/A | |
| Janice Babiak | Walgreens Boots Alliance | 60 | |
| Pingfan Wu | China Jo Jo Drugstores | 52 | |
| Gene Burleson | SunLink Health Systems | 77 | |
| William Foote | Walgreens Boots Alliance | 66 | |
| Taihong Guo | China Jo Jo Drugstores | 66 | |
| Howard Turner | SunLink Health Systems | 76 | |
| Steven Baileys | SunLink Health Systems | 64 | |
| Dominic Murphy | Walgreens Boots Alliance | 50 | |
| Caroline Wang | China Jo Jo Drugstores | 30 | |
| Gian Fulgoni | PetMed Express | 69 | |
| David Brailer | Walgreens Boots Alliance | 58 | |
| Jiangliang He | China Jo Jo Drugstores | 55 | |
| C Ford | SunLink Health Systems | 79 | |
| Ju Li | Bimi International Medical | 39 | |
| Karen Brenner | SunLink Health Systems | 63 | |
| Ginger Graham | Walgreens Boots Alliance | 62 | |
| Zhimin Su | China Jo Jo Drugstores | 38 | |
| Christopher Mills | SunLink Health Systems | 67 | |
| Mia Ching | Bimi International Medical | 49 | |
Management Performance
| Return On Equity | -26.29 | |||
| Return On Asset | 8.0E-4 |
Rite Aid Leadership Team
Elected by the shareholders, the Rite Aid's board of directors comprises two types of representatives: Rite Aid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rite. The board's role is to monitor Rite Aid's management team and ensure that shareholders' interests are well served. Rite Aid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rite Aid's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Heyward Donigan, President, Chief Executive Officer, Director | ||
| Elizabeth Burr, Independent Director | ||
| Frank Vitrano, Chief Officer | ||
| Douglas Donley, Chief Accounting Officer, Senior Vice President | ||
| Michael Regan, Lead Independent Director | ||
| Trent Kruse, Senior Vice President of Investor Relations, Treasury | ||
| Jessica Kazmaier, Chief Human Resource Officer | ||
| Lance Neill, Chief Operating Officer | ||
| Brian Hoover, Chief Accounting Officer | ||
| David Jessick, Independent Director | ||
| Katherine Quinn, Independent Director | ||
| Bruce Bodaken, Independent Chairman of the Board | ||
| Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer | ||
| David Abelman, Executive Vice President - Marketing | ||
| Frank Savage, Independent Director | ||
| Marcy Syms, Independent Director | ||
| James Comitale, Senior Vice President General Counsel, Secretary | ||
| Byron Purcell, VP Treasurer | ||
| Justin Mennen, Executive Vice President, Chief Information Officer | ||
| Dedra Castle, Chief Human Resource Officer, Executive Vice President | ||
| Erik Keptner, Senior Vice President Chief Marketing Officer | ||
| Marc Strassler, Corporate Counsel | ||
| Kenneth Martindale, Pres and CEO of Rite Aid Stores | ||
| Derek Griffith, Executive Vice President - Store Operations | ||
| Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP | ||
| Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations | ||
| Matthew Schroeder, Chief Financial Officer, Executive Vice President | ||
| Robert Knowling, Independent Director | ||
| Doug Donley, Chief Accounting Officer, Senior Vice President | ||
| Joseph Anderson, Independent Director | ||
| Angele RobinsonGaylord, Senior Vice President - Store Development | ||
| Jim Peters, Chief Operating Officer | ||
| Bari Harlam, Independent Director | ||
| Christopher Hall, VP Services | ||
| Arun Nayar, Independent Director | ||
| Paul Gilbert, Executive Vice President, General Counsel, Company Secretary | ||
| Myrtle Potter, Director | ||
| Kevin Lofton, Independent Director | ||
| Kermit Crawford, President COO | ||
| Chris Bohrer, Senior Vice President - Payor and Strategic Initiatives | ||
| Steve Rempel, Senior Vice President CIO | ||
| Roxanne Schwans, Senior Vice President - Market Access and Pharmacy Purchasing | ||
| Enio Montini, Executive Vice President - Merchandising | ||
| Louis Miramontes, Independent Director | ||
| Joy Seusing, VP Officer | ||
| Heyward BA, CEO Pres | ||
| Andre Persaud, Executive Vice President - Retail | ||
| Bryan Everett, Executive Vice President - Store Operations | ||
| John Standley, Chairman, CEO and Chairman of Executive Committee | ||
| James Peters, Chief Operating Officer |
Rite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rite Aid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -26.29 | |||
| Return On Asset | 8.0E-4 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.0004 % | |||
| Current Valuation | 6.08 B | |||
| Shares Outstanding | 56.7 M | |||
| Shares Owned By Insiders | 2.66 % | |||
| Shares Owned By Institutions | 49.33 % | |||
| Number Of Shares Shorted | 18.07 M | |||
| Price To Earning | 0.86 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Rite Aid information on this page should be used as a complementary analysis to other Rite Aid's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Rite Stock
If you are still planning to invest in Rite Aid check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rite Aid's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |